1702 Patients enrolled in the accelerating medicines partnership (AMP) RA/SLE network with isolated renal disease report minimal quality of life impairment on PROMIS-29 compared to patients with extrarenal symptoms

• ,
• Richard Furie,
• Michelle Petri,
• Judith A James,
• Kenneth Kalunian,
• Maria Dall’Era,
• Jill Buyon,
• Chaim Putterman,
• Peter Izmirly,
• Betty Diamond,
• Jessica Li,
• Jennifer Anolik,
• H Michael Belmont,
• Philip Carlucci,
• Deepak Rao,
• Andrea Fava,
• Diane Kamen,
• Celine Berthier,
• Jose Monroy-Trujillo,
• Kristin Haag,
• William Apruzzese,
• Sean Connery,
• Fernanda Payan-Schober,
• Kerry Cho,
• Kristina Deonaraine,
• Derek Fine,
• Heather T Gold,
• Susana Serrate-Sztein

Affiliations

4Global Patient Safety, BioPharmaceuticals, RandD, AstraZeneca, Gaithersburg, MD, USA

Richard Furie

2 Division of Rheumatology, Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Great Neck, New York, USA

Michelle Petri

Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Judith A James

8 Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA

Kenneth Kalunian

University of California San Diego School of Medicine, La Jolla, CA, USA

Maria Dall’Era

5 Department of Rheumatology, University of California San Francisco, San Francisco, CA, United States

Jill Buyon

Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, USA

Chaim Putterman

Division of Rheumatology and Department of Microbiology and Immunology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA

Peter Izmirly

1 Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA

Betty Diamond

Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, New York, USA

Jessica Li

Division of Rheumatology, Johns Hopkins University, Baltimore, MD, USA

Jennifer Anolik

Department of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, NY, USA

H Michael Belmont

1New York University School of Medicine, USA

Philip Carlucci

1 Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, Maryland, USA

Deepak Rao

Medicine, Princess Royal University Hospital, Orpington, UK

Andrea Fava

Division of Rheumatology, Johns Hopkins University, Baltimore, MD, USA

Diane Kamen

6Department of Rheumatology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA

Celine Berthier

2Molecular Nephroplogy Research Lab, U. of Michigan

Jose Monroy-Trujillo

Division of Rheumatology, Johns Hopkins University, Baltimore, MD, USA

Kristin Haag

Division of Rheumatology, Johns Hopkins University, Baltimore, MD, USA

William Apruzzese

Division of Rheumatology, Inflammation, Immunity, Department of Medicine, Brigham and Women`s Hospital, Harvard Medical School, Boston, MA, USA

Sean Connery

Department of Internal Medicine, Paul L Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX, USA

Fernanda Payan-Schober

Department of Internal Medicine, Paul L Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX, USA

Kerry Cho

Nephrology Division, University of California San Francisco, San Francisco, CA, USA

Kristina Deonaraine

2University at Buffalo, USA

Derek Fine

5Johns Hopkins University, Baltimore, MD, USA

Heather T Gold

1New York University School of Medicine, New York, NY, USA

Susana Serrate-Sztein

15National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, USA